BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7601012)

  • 1. Diagnosis and treatment of gastric cancer.
    Hendlisz A; Bleiberg H
    Drugs; 1995 May; 49(5):711-20. PubMed ID: 7601012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the treatment of gastric carcinoma.
    Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide in gastric cancer.
    Macdonald JS; Havlin KA
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
    Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
    J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of gastric cancer.
    Schipper DL; Wagener DJ
    Anticancer Drugs; 1996 Feb; 7(2):137-49. PubMed ID: 8740718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [European School of Oncology (ESO)--gastric cancer treatment strategy].
    Ogawa M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):277-9. PubMed ID: 1736843
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
    Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
    Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
    Hartgrink HH; van de Velde CJ; Putter H; Songun I; Tesselaar ME; Kranenbarg EK; de Vries JE; Wils JA; van der Bijl J; van Krieken JH;
    Eur J Surg Oncol; 2004 Aug; 30(6):643-9. PubMed ID: 15256239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies in the management of locoregional and metastatic gastric carcinoma.
    Ajani JA; Ota DM; Jackson DE
    Cancer; 1991 Jan; 67(1 Suppl):260-5. PubMed ID: 1984825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of gastric cancer].
    Konishi T; Teruya M; Kawahara M; Itoh A; Asakura R; Araki S; Hojo K; Nouchi T; Takeda Y
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):504-15. PubMed ID: 9530356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in therapy for gastric cancer.
    Yeh KH; Cheng AL
    J Formos Med Assoc; 2004 Mar; 103(3):171-85. PubMed ID: 15124044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancers of the stomach].
    Dominguez S; Adenis A
    Bull Cancer; 2001 Nov; 88(11):1105-18. PubMed ID: 11741805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
    Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
    Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neo-adjuvants, adjuvants and palliative therapy for gastric carcinoma].
    Klein HO
    Praxis (Bern 1994); 1998 Mar; 87(13):451-4. PubMed ID: 9584571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.